AI Article Synopsis

  • Angioedema with eosinophilia is categorized into two types: episodic, known as Gleich's syndrome, and non-episodic, which was the focus of a case study involving a young lactating woman.
  • The patient's examination revealed significant non-pitting edema in her lower extremities, but no other symptoms or complications were present, leading to a diagnosis of non-episodic angioedema.
  • The study also investigated the relationship between specific cytokines and chemokines related to edema in the patient, discovering a strong correlation among several inflammatory markers, marking this as a pioneering research effort in understanding this condition.

Article Abstract

Angioedema with eosinophilia is classified into two types: episodic angioedema with eosinophilia (EAE), known as Gleich's syndrome, and non-episodic angioedema with eosinophilia (NEAE). We present the case of a young lactating woman with non-episodic angioedema. She had no history of parasitic or nonparasitic infections. Physical examination showed striking, non-pitting edema in both lower extremities. Her weight had not changed significantly throughout the course of the illness. She exhibited no other symptoms, and her vital signs were normal. There was no evidence of anemia, hypoalbuminemia, thyroid dysfunction, heart failure, renal failure, or postpartum cardiomyopathy. Based on these findings, we diagnosed her with angioedema with eosinophilia. Given the scarcity of information about this condition, we explored the dynamics between cytokines/chemokines and edema in this patient. We successfully quantified the edema by bioimpedance analysis. In addition, we revealed the involvement of interleukin-5 (IL-5), thymus- and activation-regulated chemokine/C-C motif chemokine ligand-17 (TARC/CCL-17), eotaxin-3/CCL-26, tumor necrosis factor-α (TNF-α), vascular endothelial growth factor (VEGF), monocyte chemotactic protein-4/CCL-13 (MCP-4/CCL-13), eotaxin-1/CCL-11, and regulated on activation, normal T expressed and secreted/CCL-5 (RANTES/CCL-5) in NEAE. Lastly, we elucidated the strong association between these parameters. To the best of our knowledge, this is the first such study of its kind.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107285PMC
http://dx.doi.org/10.3389/fimmu.2021.627360DOI Listing

Publication Analysis

Top Keywords

angioedema eosinophilia
20
non-episodic angioedema
12
young lactating
8
lactating woman
8
angioedema
6
eosinophilia
5
case report
4
report non-episodic
4
eosinophilia young
4
woman angioedema
4

Similar Publications

COVID-19 and severe cutaneous allergic reactions to sulfonamides.

Allergy Asthma Proc

November 2024

From the Section of Allergy, Asthma and Immunology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, Pennsylvania and.

Sulfonamides are associated with severe cutaneous adverse reactions (SCARs). Coronavirus disease 2019 (COVID-19) triggers an immune response, which may increase the likelihood of developing a hypersensitivity reaction. We sought to explore the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the probability of developing SCARs and/or erythema multiforme (EM) reactions to sulfonamides.

View Article and Find Full Text PDF

Non-episodic angioedema with eosinophilia as a differential diagnosis of eosinophilia in young females.

World Allergy Organ J

November 2024

Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Background: Episodic angioedema with eosinophilia, also known as Gleich's syndrome, is a differential diagnosis in patients with recurrent angioedema with higher blood eosinophils. Meanwhile, less has been elucidated regarding non-episodic angioedema with eosinophilia (NEAE). This study aimed to examine the prevalence, clinical characteristics, and disease course of NEAE.

View Article and Find Full Text PDF
Article Synopsis
  • Loiasis, caused by the Loa loa worm and affecting around 10 million people in Central Africa, presents challenges in diagnosis and treatment due to potential severe reactions to ivermectin used for other infections.
  • Diagnosis typically involves identifying adult worms or microfilariae in blood, but many infections are "occult," prompting the need for new diagnostic tools.
  • This study compared two serological rapid antibody tests for loiasis and onchocerciasis, evaluating their effectiveness in diagnosing infections among participants, revealing a high prevalence of both microfilaremia and symptoms related to loiasis.
View Article and Find Full Text PDF

Beyond IL-5 inhibition for the treatment of episodic angioedema with eosinophilia (Gleich syndrome).

J Allergy Clin Immunol

November 2024

Service de médecine interne et d'immunologie clinique, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), CHU Lille, Lille, France; Université de Lille, INSERM U1286 INFINITE - Institute for Translational Research in Inflammation, Lille, France; Laboratoire d'immunologie, CHU Lille, Lille, France.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!